MedPath

Exploring Taiwanese Womens' Decision-making Regarding Vaginal Birth After Caesarean Section

Completed
Conditions
Caesarean Section
Registration Number
NCT01210300
Lead Sponsor
Taipei Medical University WanFang Hospital
Brief Summary

The incidence of caesarean section (CS) has increased globally. Taiwan's statistics report a higher incidence of repeat CS compared to vaginal birth after caesarean (VBAC). This is concerning, as repeat CS are associated with increased maternal morbidity and mortality, and neonatal respiratory problems. VBAC is an approach which reduces the likelihood of such birth complications. However, there is limited information about Taiwanese women's decision regarding VBAC and their participation in decision-making. There is also a gap in literature about information for women about CS and VBAC.

Detailed Description

Ajzen's Theory of Planned Behaviour will theoretically underpin the study. A qualitative descriptive design using purposive sampling of 20 Taiwanese pregnant women who have previously had a CS with a live baby will be recruited from Chang Gung Memorial Hospital in Taiwan. In-depth interviews will be carried out in three phases: (1) between 34 weeks to 38 weeks of women's pregnancy; (2) on the third day after childbirth; and (3) at the fourth week after birth, the end of confinement. Boyatzis' Data Driven approach will be adopted to thematically analyze the data.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • Have had a previous CS with a live baby
  • Currently at 34 to 38 weeks of pregnancy
  • Medically eligible for a VBAC
  • Have chosen to have a natural birth
  • 20 years old and over
  • Able to converse in Mandarin and/or Taiwanese
Exclusion Criteria
  • Previous myomectomy
  • Previous classical caesarean section
  • Two previous caesarean section
  • Pregnant with complications

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chang Gung Institute of Technology

🇨🇳

Taoyuan, Taiwan

© Copyright 2025. All Rights Reserved by MedPath